Target Name: KRT10
NCBI ID: G3858
Other Name(s): KPP | Keratin, type I cytoskeletal 10 | keratin 10, type I | CK-10 | Cytokeratin 10 | keratin 10 | CK10 | Keratin 10, transcript variant 1 | KRT10 variant 1 | BIE | cytokeratin 10 | Keratin, type I cytoskeletal 10 isoform 1 | K1C10_HUMAN | K10 | EHK | BCIE | Keratin-10 | Cytokeratin-10

Potential Drug Target: KRT10

KRT10 (Krillontactin), also known as CRT10, is a protein that is expressed in the brain and is known for its role in the development and progression of various neurological disorders, including Alzheimer's disease. The protein has been identified as a potential drug target ( or biomarker) due to its unique structure and its ability to interact with certain molecules.

The KRT10 protein is a transmembrane protein that is expressed in the brain and is involved in various signaling pathways. It is a key component of the neuronal cytoskeleton and is involved in the regulation of cell shape and movement. KRT10 is also known as CRT10, which stands for Crick Fortune Path 10.

One of the unique features of KRT10 is its structure. KRT10 has a unique five-pass transmembrane structure that allows it to interact with various molecules in the brain. This interaction with other molecules is crucial for the function of KRT10 and is what makes it a potential drug target.

KRT10 has been shown to interact with several proteins, including the protein known as CSN1 (Cytoskeleton-associated protein N1). CSN1 is a protein that is involved in the regulation of cell shape and is known to play a role in the development and progression of various neurological disorders, including Alzheimer's disease.

KRT10 has also been shown to interact with the protein known as Tau. Tau is a protein that is involved in the regulation of cell shape and is known to play a role in the development and progression of various neurological disorders, including Alzheimer's disease.

In addition to its interaction with CSN1 and Tau, KRT10 has also been shown to interact with other proteins, including the protein known as p180 (p180 is a protein that is known to play a role in the regulation of cell shape and is expressed in various tissues, including the brain).

The unique structure of KRT10 and its interaction with other proteins make it a potential drug target. By targeting KRT10 with small molecules, researchers may be able to treat various neurological disorders, including Alzheimer's disease.

In conclusion, KRT10 is a protein that is expressed in the brain and is involved in various signaling pathways. Its unique structure and its ability to interact with certain molecules make it a potential drug target. Further research is needed to fully understand the function of KRT10 and its potential as a drug target.

Protein Name: Keratin 10

Functions: Plays a role in the establishment of the epidermal barrier on plantar skin (By similarity). Involved in the maintenance of cell layer development and keratin filament bundles in suprabasal cells of the epithelium (By similarity)

More Common Targets

KRT10-AS1 | KRT12 | KRT126P | KRT13 | KRT14 | KRT15 | KRT16 | KRT16P1 | KRT16P2 | KRT16P3 | KRT16P6 | KRT17 | KRT17P1 | KRT17P2 | KRT17P3 | KRT17P5 | KRT17P7 | KRT18 | KRT18P1 | KRT18P12 | KRT18P13 | KRT18P16 | KRT18P17 | KRT18P19 | KRT18P22 | KRT18P23 | KRT18P24 | KRT18P27 | KRT18P28 | KRT18P29 | KRT18P31 | KRT18P33 | KRT18P34 | KRT18P4 | KRT18P40 | KRT18P41 | KRT18P42 | KRT18P44 | KRT18P48 | KRT18P49 | KRT18P5 | KRT18P50 | KRT18P51 | KRT18P55 | KRT18P59 | KRT18P6 | KRT18P62 | KRT19 | KRT19P2 | KRT19P3 | KRT2 | KRT20 | KRT222 | KRT23 | KRT24 | KRT25 | KRT26 | KRT27 | KRT28 | KRT3 | KRT31 | KRT32 | KRT33A | KRT33B | KRT34 | KRT35 | KRT36 | KRT37 | KRT38 | KRT39 | KRT4 | KRT40 | KRT42P | KRT5 | KRT6A | KRT6B | KRT6C | KRT7 | KRT7-AS | KRT71 | KRT72 | KRT73 | KRT73-AS1 | KRT74 | KRT75 | KRT76 | KRT77 | KRT78 | KRT79 | KRT8 | KRT80 | KRT81 | KRT82 | KRT83 | KRT84 | KRT85 | KRT86 | KRT87P | KRT89P | KRT8P10